Prentice, Kacey J.
Saksi, Jani
Robertson, Lauren T.
Lee, Grace Y.
Inouye, Karen E.
Eguchi, Kosei
Lee, Alexandra
Cakici, Ozgur
Otterbeck, Emily
Cedillo, Paulina
Achenbach, Peter http://orcid.org/0000-0001-6720-2684
Ziegler, Anette-Gabriele
Calay, Ediz S.
Engin, Feyza http://orcid.org/0000-0002-7987-5381
Hotamisligil, Gökhan S. http://orcid.org/0000-0003-2906-1897
Article History
Received: 12 August 2020
Accepted: 14 October 2021
First Online: 8 December 2021
Competing interests
: The Hotamisligil Lab has generated intellectual property (assigned to Harvard University) related to hormonal FABP4 and its therapeutic targeting and receives funding for this project from Lab1636, LLC, an affiliate of Deerfield Management. G.S.H. is on the Scientific Advisory Board of Crescenta Pharmaceuticals and holds equity. Other authors have no conflicts of interest to declare.